Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Laura Godfrey

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2393-9881; OpenAlex author ID A5013612450, A5157836003. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
44
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 7

  1. Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41467-026-69013-y↗
  2. Loss of the Y chromosome drives basal identity and metastatic potential via epigenetic reprogramming in pancreatic cancer Co-author DOI 10.64898/2026.10.06.756936↗
  3. PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2025.115541↗
  4. Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. Co-author DOI 10.1186/s13148-024-01623-z↗
  5. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype. First author DOI 10.1136/gutjnl-2021-326550↗
  6. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s40170-022-00298-5↗
  7. Functional metabolic phenotyping of human pancreatic ductal adenocarcinoma Co-author DOI 10.1101/2021.07.23.452145↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jens Thomas Siveke · 7 shared papers, 2021–2026 · strength 1.12
  2. Marija Trajkovic‐Arsic · 5 shared papers, 2021–2026 · strength 0.77
  3. Sven‐Thorsten Liffers · 3 shared papers, 2023–2026 · strength 0.52
  4. Phyllis F. Cheung · 3 shared papers, 2021–2026 · strength 0.40
  5. Stephan A. Hahn · 3 shared papers, 2021–2025 · strength 0.40
  6. Smiths Lueong · 3 shared papers, 2021–2025 · strength 0.40
  7. Rickmer Braren · 3 shared papers, 2021–2026 · strength 0.40
  8. Madeleine Dorsch · 2 shared papers, 2025–2026 · strength 0.40
  9. Barbara T. Grünwald · 2 shared papers, 2026 · strength 0.40
  10. Barbara M. Grüner · 2 shared papers, 2025–2026 · strength 0.40
  11. Diana Behrens · 2 shared papers, 2024–2026 · strength 0.37
  12. Rita Teresa Lawlor · 2 shared papers, 2024–2026 · strength 0.37
  13. Aldo Scarpa Scarpa · 2 shared papers, 2024–2026 · strength 0.37
  14. Rui Fang · 1 shared paper, 2025 · strength 0.20
  15. Juanfei Peng · 1 shared paper, 2026 · strength 0.20
  16. Markus Vogt · 1 shared paper, 2026 · strength 0.20
  17. Elmar Wolf · 1 shared paper, 2026 · strength 0.20
  18. Hendrik Schürmann · 1 shared paper, 2025 · strength 0.20
  19. Niklas Krebs · 1 shared paper, 2026 · strength 0.20
  20. Ben Zhao · 1 shared paper, 2025 · strength 0.20
  21. Andrea Tannapfel · 2 shared papers, 2021–2022 · strength 0.20
  22. Erik H.J.G. Aarntzen · 2 shared papers, 2021–2022 · strength 0.20
  23. Waldemar H. Uhl · 2 shared papers, 2021–2022 · strength 0.20
  24. E. Smeets · 2 shared papers, 2021–2022 · strength 0.20
  25. Irina Heid · 2 shared papers, 2021–2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.